Elder Pharmaceuticals, a Rs.950 crore plus Mumbai based pharma major, has reported satisfactory performance during the third quarter ended December 2011 and its net profit increased by 15.5 per cent to Rs.18.29 crore from Rs.15.94 crore in the same period of last year. Its consolidated net sales moved up by 36.4 per cent to Rs.343.12 crore from Rs.251.54 crore.

The earnings per share worked out to Rs.8.91 as compared to Rs.7.71 in the last period. For the nine months period ended December 2011, its consolidated net sales increased by 48.3 per cent to Rs.873.86 crore from Rs.656.49 crore in the last period. Its net profit increased by 25 per cent to Rs.57.75 crore from Rs.46.19 crore.

The company's standalone net sales for the quarter under review increased by 22.5 per cent to Rs.256.81 crore and its net profit moved up by 25.7 per cent to Rs.22.71 crore and for the first nine months of 2011-12, its standalone net sales improved by 21.3 per cent to Rs.733 crore and its net profit by 29.1 per cent to Rs.68.52 crore.

Date: 3th feb,2012